News

On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device ...
On track to implant first patients in long-term, multicenter feasibility study of the fully implantable continuous blood glucose monitor (CBGM) system in Australia in Q3 2025 Investigational Device Ex ...
An acute internal jugular, subclavian, or axillary DVT is a relatively ... with an internal jugular vein thrombosis being the most common source. The inconsistent use of anticoagulation therapy ...
The first evaluation for subclavian artery occlusive disease should always be a simple measurement of bilateral brachial artery blood pressures. A significant difference between the two ...
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq ...
For patients undergoing CABG, the no-touch group showed a significantly lower vein graft occlusion rate compared with the conventional group, with an absolute risk difference of −3.2%. HealthDay News ...
The local architect assumes leadership of the La Jolla Community Planning Association with the perspective ...